Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Nitrite-NO bailout for a NOS complex too big to fail

Cellular production of nitric oxide (NO) by nitric oxide synthase (NOS) in the face of limiting pools of arginine requires the intracellular citrulline-to-NO pathway, catalyzed by the enzyme argininosuccinate lyase (ASL). People with the urea cycle disorder argininosuccinic aciduria, caused by a deficiency of ASL, have systemic NO deficiency, which can be rescued by the use of an alternative, NOS-independent, nitrite-to-NO pathway.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Intracellular arginine, produced by citrulline metabolism or imported through CAT1, is oxidized to citrulline and NO by eNOS.

References

  1. McDonald, K.K., Zharikov, S., Block, E.R. & Kilberg, M.S. J. Biol. Chem. 272, 31213–31216 (1997).

    Article  CAS  Google Scholar 

  2. Brunetti-Pierri, N., Erez, A., Shchelochkov, O., Craigen, W. & Lee, B. Mol. Genet. Metab. 98, 195–197 (2009).

    Article  CAS  Google Scholar 

  3. Erez, A. et al. Nat. Med. 17, 1619–1626 (2011).

    Article  CAS  Google Scholar 

  4. Cosby, K. et al. Nat. Med. 9, 1498–1505 (2003).

    Article  CAS  Google Scholar 

  5. Gladwin, M.T. et al. Proc. Natl. Acad. Sci. USA 97, 11482–11487 (2000).

    Article  CAS  Google Scholar 

  6. Lundberg, J.O., Weitzberg, E. & Gladwin, M.T. Nat. Rev. Drug. Discov. 7, 156–167 (2008).

    Article  CAS  Google Scholar 

  7. Li, H., Kundu, T.K. & Zweier, J.L. J. Biol. Chem. 284, 33850–33858 (2009).

    Article  CAS  Google Scholar 

  8. Li, H., Samouilov, A., Liu, X. & Zweier, J.L. J. Biol. Chem. 276, 24482–24489 (2001).

    Article  CAS  Google Scholar 

  9. Zweier, J.L., Wang, P., Samouilov, A. & Kuppusamy, P. Nat. Med. 1, 804–809 (1995).

    Article  CAS  Google Scholar 

  10. Alef, M.J. et al. J. Clin. Invest. 121, 1646–1656 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mark T Gladwin.

Ethics declarations

Competing interests

M.T.G. is listed as a co-inventor on an US National Institutes of Health government patent for the use of nitrite salts in cardiovascular conditions. He has a collaborative agreement between the US government and INO Pharmaceuticals and a collaborative agreement with Bayer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gladwin, M., Tejero, J. Nitrite-NO bailout for a NOS complex too big to fail. Nat Med 17, 1556–1557 (2011). https://doi.org/10.1038/nm.2591

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2591

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing